Image

Implementing Suicide Prevention Into Primary Care in Nepal

Implementing Suicide Prevention Into Primary Care in Nepal

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Suicide remains a major contributor to global mortality, with particularly high and persistent rates in low-resourced settings such as South Asia. In Nepal, ongoing integration of mental health services into primary care provides a critical opportunity to strengthen suicide risk assessment and management. Despite the scale-up of mhGAP training for primary care providers (PCPs), gaps remain in the systematic detection, referral, and follow-up of individuals at risk for suicide. There is an urgent need to enhance mhGAP implementation with strategies that address provider workload, stigma, and inequities within the health workforce.

Using experience-based co-design principles and RE-AIM this study will assess the feasibility and acceptability of integrating an implementation strategy package to optimize mhGAP suicide prevention delivery in Nepal's decentralized primary healthcare system. This clinical trial leverages deep collaboration with a community advisory board of individuals with lived experience of suicide throughout the trials' design, delivery and analysis.

This R34 will generate critical preliminary evidence on the feasibility, acceptability, and implementation of an integrated suicide prevention package within government primary care facilities in Nepal. The findings will inform the design and parameters of a future fully powered effectiveness trial, while aligning with Nepal's national suicide prevention strategy and advancing WHO and NIMH global mental health priorities.

Eligibility

Inclusion Criteria:

Primary Care Providers

  • Health workers with a prescribing license employed in government health facilities in Bagmati Province.
  • Are between 21-65 years, per government health system criteria.
  • Participants will be required to have competency in Nepali, be actively engaged in care provision within their health facility
    Patients
  • Patient lives in the study site
  • Is under the care of a PCP at a facility site.
  • Patient meets any level of suicide risk based on mhGAP 2.0 criteria.
  • Patients who have been treated for mental illness before or presently (expected in both groups).
  • Speaks Nepali.
  • Levels of Suicide Risk (as defined by mhGAP 2.0)

Exclusion Criteria:

Primary Care Providers

  • Healthcare workers without proper government credentials will be excluded.
  • Health workers who plan to migrate or who do not intend to stay in the study area for at least a year.
    Patients
  • Patient requiring immediate hospitalization
  • Unable to consent as determined by the diminished capacity tool.

Study details
    Suicide
    Primary Care

NCT07362056

Yale University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.